Select Medical Eyes 4.1% Revenue Growth to $1.37B and $0.23 EPS
Select Medical reported $1.36 billion in revenue last quarter, a 7.2% year-on-year increase that topped analysts’ estimates by 2.7%. Analysts forecast this quarter’s revenue to rise 4.1% to $1.37 billion with adjusted EPS of $0.23, while shares sit at $16.38 against an $18.40 price target after a 7.8% one-month gain.
1. Last Quarter Performance
Select Medical posted $1.36 billion in revenue in the last quarter, marking a 7.2% year-on-year increase and exceeding analysts’ revenue estimates by 2.7%. The company also delivered an EPS beat, underscoring continued top-and-bottom-line strength.
2. Q4 Earnings Expectations
Analysts are projecting this quarter’s revenue to grow 4.1% year-on-year to $1.37 billion, alongside adjusted EPS of $0.23 per share, indicating a moderation from the 7.8% revenue growth recorded in the same period last year.
3. Peer Results and Stock Momentum
Healthcare peers DaVita and Encompass Health both reported 9.9% year-on-year revenue gains, with DaVita topping forecasts by 3.2% and Encompass matching consensus. Select Medical’s shares have risen 7.8% over the past month and trade at $16.38 versus an $18.40 price target.